TRDA logo

Entrada Therapeutics (TRDA) Enterprise Value

Enterprise Value

$349.73 M
-$6.02 M-1.69%

Thu, 06 Mar 2025 21:05:04 GMT


Summary


Performance

TRDA Enterprise Value Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

OtherTRDAvaluationmetrics:

Enterprise Value Formula

Enterprise Value = Market Cap + Total Debt − Cash & Cash Equivalents

TRDA Enterprise Value Trends

PeriodPeriodEnterprise valueEnterprise valueMarket capMarket capPricePrice
todaytoday-1.7%-1.5%-1.5%
1 m1 month-24.7%-22.7%-22.7%
3 m3 months-54.3%-51.5%-51.7%
6 m6 months-18.6%-28.9%-29.6%
ytdytd-42.5%-39.7%-39.7%
1 y1 year-15.6%-5.9%-15.9%
5 y5 years---

TRDA Enterprise Value Highs & Lows

PeriodPeriodHighHighCurrent vs highvs highLowLowCurrent vs lowvs low
1 m1-month-24.8%$350 Mat low
3 m3-month$774 M-54.8%$350 Mat low
6 m6-month$774 M-54.8%$350 Mat low
1 y1-year$774 M-54.8%$350 Mat low
3 y3-year$774 M-54.8%-$35 M+1087.2%
5 y5-year$972 M-64.0%-$42 M+941.1%
alltimeall time$972 M-64.0%-$42 M+941.1%

Entrada Therapeutics Enterprise Value History

DateValue
2025
$349.73 M(-42.4%)
2024
$607.66 M(+20.3%)
DateValue
2023
$505.20 M(+24.7%)
2022
$405.24 M(+66.4%)
2021
$243.50 M

FAQ

  • What is Entrada Therapeutics enterprise value?
  • What is the all time high enterprise value for Entrada Therapeutics?
  • What is TRDA enterprise value year-to-date change?
  • What is Entrada Therapeutics enterprise value year-on-year change?

What is Entrada Therapeutics enterprise value?

The current enterprise value of TRDA is $349.73 M

What is the all time high enterprise value for Entrada Therapeutics?

Entrada Therapeutics all-time high enterprise value is $971.53 M

What is TRDA enterprise value year-to-date change?

Entrada Therapeutics enterprise value has changed by -$257.93 M (-42.45%) since the beginning of the year

What is Entrada Therapeutics enterprise value year-on-year change?

Over the past year, TRDA enterprise value has changed by -$64.58 M (-15.59%)